Detalles de la búsqueda
1.
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(9): 1180-1188, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35964621
2.
Risk of lung cancer among women in relation to lifetime history of tobacco smoking: a population-based case-control study in France (the WELCA study).
BMC Cancer
; 21(1): 711, 2021 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34134640
3.
Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
BMC Cancer
; 21(1): 117, 2021 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33541288
4.
Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study.
BMC Cardiovasc Disord
; 19(1): 212, 2019 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31519196
5.
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial.
Eur Respir J
; 52(4)2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262574
6.
Women Epidemiology Lung Cancer (WELCA) study: reproductive, hormonal, occupational risk factors and biobank.
BMC Public Health
; 17(1): 324, 2017 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28415992
7.
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers.
Eur Respir J
; 45(5): 1403-14, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25657019
8.
Second-line therapy in elderly patients with advanced nonsmall cell lung cancer.
Eur Respir J
; 43(1): 240-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24114964
9.
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.
Lancet
; 378(9796): 1079-88, 2011 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-21831418
10.
Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study.
Cancers (Basel)
; 14(16)2022 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36010872
11.
Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study.
Target Oncol
; 17(6): 675-682, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36129569
12.
Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study).
Int J Environ Res Public Health
; 19(23)2022 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36498320
13.
Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies.
Lancet Reg Health Eur
; 22: 100492, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36108315
14.
Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients.
Cancers (Basel)
; 13(5)2021 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33801285
15.
Synchronous Oligometastatic Lung Cancer Deserves a Dedicated Management.
Ann Thorac Surg
; 107(4): 1053-1059, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30476480
16.
Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer.
Cancer Lett
; 464: 5-14, 2019 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31404614
17.
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study.
Lung Cancer
; 137: 149-156, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31600593
18.
Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody.
Cancer Lett
; 444: 147-161, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30583074
19.
Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer.
ERJ Open Res
; 4(2)2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29692997
20.
Rationale and delineation of a composite index of relative antitumoural efficacy (In-RATE).
Crit Rev Oncol Hematol
; 64(2): 106-14, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17681785